Bienvenido a Med Info Alert, el servicio de literatura científica de Boehringer Ingelheim que te permite estar al día de las publicaciones más recientes y relevantes sobre la enfermedad pulmonar intersticial difusa (EPID).
Si estás interesado en recibir alguna publicación de este mes, a continuación, puedes descargarla o acceder a tu cuenta para solicitarla.
¿También quieres estar actualizado los próximos meses con las publicaciones más recientes sobre EPID? Regístrate en avances en fibrosis pulmonar.
Gregor J, et al. The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry. Arch Bronconeumol. 2024
Raghu G, et al. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency. Am J Respir Crit Care Med. 2024
Huang X, et al. Novel 3D-based deep learning for classification of acute exacerbation of idiopathic pulmonary fibrosis using high-resolution CT. BMJ Open Respir Res. 2024
Rubio-Rivas M, et al. Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis. Rev Clin Esp (Barc). 2024
García Sevila R, et al. Nintedanib in chronic fibrosing interstitial lung diseases. A case series. Heliyon. 2024
Höppner J, et al. Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study. Arch Rheumatol. 2024
Enomoto N, et al. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study. Respir Med. 2024
Buschulte K, et al. Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry. Respir Res. 2024
Kawano-Dourado L, et al. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases. Thorax. 2024
PC-ES-112836